Literature DB >> 27809714

The regulation of Sema4D exodomain shedding by protein kinase A in platelets.

T Chen1, D Z Xu1, Q Li1, P Mou1, Z Zeng1, L F Brass2,3, L Zhu1.   

Abstract

We have previously shown that Sema4D expressed on the platelet plasma membrane can be cleaved by the metalloprotease ADAM17, producing a 120-kDa exodomain fragment that retains biological activity and remnant fragments of 24-28 kDa that remain associated with the platelet membrane. This process is modulated by calmodulin. Here we investigated the potential role of protein kinase A (PKA) in these events. Using a pharmacological approach, we now show that inhibition of PKA by H89 is sufficient to induce Sema4D exodomain shedding, while activation of PKA inhibits agonist-initiated shedding. Studies on the regulatory mechanism show that the shedding induced by PKA inhibition is mediated by ADAM17, but, unlike agonist-induced shedding, does not involve the dissociation of calmodulin from the Sema4D cytoplasmic domain. In attempt to identify the cleavage sites for shedding, we found that ADAM17 mediates variable cleavages in the juxtamembrane region. Therefore, our data reveal a potential regulatory mechanism for the shedding of Sema4D in platelets.

Entities:  

Keywords:  PKA; Platelets; Sema4D

Mesh:

Substances:

Year:  2016        PMID: 27809714     DOI: 10.3109/09537104.2016.1154141

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  4 in total

1.  Sema4D expression and secretion are increased by HIF-1α and inhibit osteogenesis in bone metastases of lung cancer.

Authors:  Wu-Gui Chen; Jing Sun; Wei-Wei Shen; Si-Zhen Yang; Ying Zhang; Xu Hu; Hao Qiu; Shang-Cheng Xu; Tong-Wei Chu
Journal:  Clin Exp Metastasis       Date:  2019-01-07       Impact factor: 5.150

Review 2.  Platelet Membrane Receptor Proteolysis: Implications for Platelet Function.

Authors:  Jiayu Wu; Johan W M Heemskerk; Constance C F M J Baaten
Journal:  Front Cardiovasc Med       Date:  2021-01-08

3.  Downregulation of ADAM17 in pediatric immune thrombocytopenia impairs proplatelet formation.

Authors:  Qi Wang; Jia Wei; Xi Jia; Xiao Feng; Zhenghua Ji; Xueqiang Ji; Xuejun Shao
Journal:  BMC Pediatr       Date:  2022-03-30       Impact factor: 2.125

Review 4.  Cyclic nucleotide-dependent inhibitory signaling interweaves with activating pathways to determine platelet responses.

Authors:  Zoltan Nagy; Albert Smolenski
Journal:  Res Pract Thromb Haemost       Date:  2018-06-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.